Find clinical trials for Melanoma in Indianapolis, IN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Melanoma trials near Indianapolis, IN, USA:
with Opdualag to subjects with unresectable or metastatic melanoma.Subjects in dose escalation (Cohorts 1 through 3) and dose expansion (Coh...
Phase 1, Phase 2
Indianapolis, Indiana, United States and 14 other locations
This is a Phase 1b/2, multi-center, open label umbrella study of patients ≥12 years of age with recurrent, progressive, or refractory melanoma...
Phase 1, Phase 2
Indianapolis, Indiana, United States and 19 other locations
The purpose of this study is to evaluate the safety and tolerability of CFT1946 as well as to determine the maximum tolerated dose (MTD) and/or the r...
Phase 1
Indianapolis, Indiana, United States and 25 other locations
A first-in-human, Phase I, open-label, multicenter study of WTX-124 administered as monotherapy and in combination with pembrolizumab to patients wit...
Phase 1
Indianapolis, Indiana, United States and 10 other locations
TTX-080-001 is a Phase 1, open label, dose escalation and dose expansion clinical study to determine the safety, tolerability, and recommended Phase...
Phase 1
Indianapolis, Indiana, United States and 38 other locations
This study will test a study drug called cemiplimab to see if it can help treat early-stage cutaneous squamous cell carcinoma (CSCC), a type of skin...
Phase 3
Indianapolis, Indiana, United States and 11 other locations
This is an open-label, multi-center, single arm, Phase II study to evaluate the efficacy and safety of T-DXd for the treatment of unresectable and/or...
Phase 2
Muncie, Indiana, United States and 29 other locations
VET3-TGI is an oncolytic immunotherapy designed to treat advanced cancers. VET3-TGI has not been given to human patients yet, and the current study i...
Phase 1
Indianapolis, Indiana, United States and 6 other locations
This is a Phase 1/2A study of GV20-0251 being developed for the treatment of participants with advanced solid tumors, who are refractory to approved...
Phase 1, Phase 2
Indianapolis, Indiana, United States and 12 other locations
or fluocinolone acetonide (FAc) intravitreal implant compared with observation on long-term visual acuity following treatment of choroidal melanoma...
Phase 3
Indianapolis, Indiana, United States and 17 other locations
Clinical trials
Research sites
Resources
Legal